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The investigation of cell lineages and clonal organization in
tissues is facilitated by techniques that allow labelling of clonal
cell lineages. Here, we describe a novel transgenic mouse that
allows clonal cell lineages to be traced in virtually any tissue. A
green fluorescent cell lineage is generated by a random mutation
at an enhanced green fluorescent protein gene that carries a
premature stop codon, ensuring clonality. The transgenic system
allows efficient detection of mutations and stem-cell fate
mapping in the epidermis using live mice, as well as in the
kidney and liver post-mortem. Cell lineages that descended from
single epidermal stem cells were found to be capable of gen-
erating three adjacent corneocytes using the system, providing
evidence for horizontal migration of epidermal cells between
epidermal proliferative units (EPUs), in contrast to the classical
EPU model. The transgenic mouse system is expected to provide
a novel tool for stem-cell lineage studies.
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INTRODUCTION
Stem cells are known to produce a variety of somatic cell types
needed for periodic tissue renewal and tissue regeneration after
injury (Van der Kooy & Weiss, 2000; Ro & Rannala, 2001). Recent
research implies that stem cells may even produce cells of
developmentally unrelated tissue types in experimentally mod-
ified conditions (Brazelton et al, 2000; Toma et al, 2001). Thus, it
is important to determine how diverse a range of cell types and
how expansive a clonal cell lineage is a single stem cell of a
particular tissue able to produce in a mammalian system in vivo.
To address these questions, a cell fate mapping technique is
needed that allows one to label single cells in a tissue and
subsequently trace their clonal cell lineages with minimal
experimental perturbations. The clonality of a cell lineage
generated by current cell fate mapping techniques, however,
is usually not guaranteed (Clarke & Tickle, 1999; Flake, 2001).
Methods using tritiated thymidine or bromodeoxyuridine simulta-
neously label large numbers of cells that are undergoing
proliferation making it unlikely that a cell lineage generated by
these methods will have originated from a single progenitor cell.
Another limitation is that signals from labelled cells are diluted out
after multiple cell divisions (Flake, 2001; Stern & Fraser, 2001).
Mapping techniques using replication-deficient retroviruses that
carry a marker gene can overcome the dilution problem.
However, the retrovirus-mediated methods can only label cells
that are undergoing proliferation. Also, labelling of single cells is
not easily achieved, even when using a very low titre of viruses,
hindering analysis of clonal cell lineages (Clarke & Tickle, 1999;
Stern & Fraser, 2001). The mouse Dolichos biflorus 1 (Dlb-1)
system relies on mutations to label individual cells and has been
used successfully for mapping of clonal cell lineages (Winton et al,
1988), but the system can only be applied to the epithelium of the
small intestine.
Here, we present a novel transgenic mouse system in which
clonal cell lineages can be generated in any tissue. Single cells
are labelled by means of random mutations that have very low
frequency, and thus the clonality of a cell lineage generated in this
system is virtually certain. The transgenic mouse that we have
developed carries a premature stop-codon-containing enhanced
green fluorescent protein (EGFP) gene as a target gene for
mutations. A cell that has undergone a mutation at the premature
stop codon and its descendant cell lineage will express EGFP;
thus, a clonal cell lineage can be traced by following a green
fluorescent colony. Cell fate mapping using the transgenic mouse
(referred to as the stop-EGFP mouse) may offer advantages over
other mapping techniques in revealing the potential of single stem
cells to provide cells to replenish other cellular compartments, or
to produce cells of diverse tissue types. Because detection of EGFP
expression in individual cells requires no additional substrates and
fluorescent imaging is by itself noninvasive, even repeated in vivo
analyses of a specific clonal cell lineage over time are feasible.
RESULTS AND DISCUSSION
The stop-EGFP gene and the wild-type EBFP gene
Okabe et al (1997) developed a ‘green mouse’ in which the EGFP
gene was ubiquitously expressed. We have obtained the plasmid
used by Okabe et al and have introduced a premature stop codon
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(TAG) between the second and third codon position of the EGFP
gene. This construct is subsequently referred to as the stop-EGFP
gene. The neutrality of the position of the premature stop codon was
verified experimentally by means of a cell transfection experiment
(Fig 1). A mutation at any one of the three nucleotides of the stop
codon will restore EGFP function except in the case of a mutation
from G to A (i.e., GC-AT transition) at the third site, which
produces another stop codon, TAA. To make up for the inability
of our stop-EGFP construct to detect a GC-AT transition mutation
at the stop codon, the wild-type enhanced blue fluorescent protein
(EBFP) gene was used as another mutational target. The EBFP gene
differs from the EGFP gene by only a single nucleotide (Heim et al,
1994); a mutation at the 196th nucleotide of the EBFP gene from
C to T (i.e., GC-AT transition) generates the wild-type EGFP gene.
A transgenic system carrying both the stop-EGFP gene and the wild-
type EBFP gene can therefore detect all possible point mutations
arising by either transitions (AT-GC and GC-AT) or transversions
(AT-TA, AT-CG, GC-TA and GC-CG).
Generation of stop-EGFP mice
Two transgenic founder mice carrying both the stop-EGFP gene
and the wild-type EBFP gene have been generated (see supple-
mentary Fig S1 online). Southern blot analysis shows that both
transgenic lines carry more than 10 copies of the transgenes (see
supplementary Fig S1 online). Expression of both the stop-EGFP
gene and the EBFP gene was confirmed by reverse-transcription–
PCR (see supplementary Fig S2 online).
In vivo detection of epidermal stem-cell clonal lineages
To investigate a clonal cell lineage that descended from a stem
cell in the epidermis, we induced mutations in an 8-week-old
stop-EGFP mouse using a potent mutagen, N-ethyl-N-nitrosourea
(ENU), and performed in vivo imaging of the dorsal skin at 6
weeks post-ENU administration. The turnover rate of the
epidermal tissue is estimated to be about 2 weeks (Potten,
1975); thus, one expects around three epidermal turnovers during
the 6-week period, so that cell lineages that originated from non-
stem-cell mutants (induced by the ENU exposure) can be expected
to have disappeared after that period. Several studies suggest that
an interval of 6 weeks after labelling is enough to eliminate
epidermal cell lineages that originated from transit amplifying (TA)
cells, allowing epidermal stem-cell lineages to be specifically
detected (Schneider et al, 2003).
In vivo imaging of the dorsal epidermis of a stop-EGFP mouse
at 6 weeks post-ENU administration revealed an epidermal stem-
cell clonal lineage containing three adjacent corneocytes (Fig 2A).
The hexagonal shape is characteristic of the morphology of a
cornified cell (corneocyte) in the outermost layer of the epidermis.
This finding is in contrast to the classical model for stem-cell
clonal lineages in the mouse dorsal epidermis (Allen & Potten,
Fig 1 | Transient expression of revertant forms of the stop-EGFP gene in the NIH3T3 cell line. Three possible revertant forms of the stop-EGFP gene,
each containing AAG (encoding lysine), TTG (encoding leucine) or TGG (encoding tryptophan) at the site of the premature stop codon, were
generated (see supplementary information online) and used for the transfection experiment. All three revertants, AAG-revertant (A), TTG-revertant
(B) and TGG-revertant (C), expressed functional proteins, which were as strongly fluorescent as the wild-type EGFP (D). The result strongly supports
the neutrality of the position of the premature stop codon. Green fluorescence from cells transfected with the stop-EGFP gene or the wild-type EBFP
gene was comparable with that from a negative control, nontransfected cells (data not shown).
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1974; Potten & Morris, 1988). The model predicts that around
10–11 basal cells (with a stem cell in the centre) are located
beneath one column of corneocytes and the TA basal cells that
descended from a central stem cell are thought to move directly
upward to differentiate terminally into corneocytes (Fig 2D). These
basal cells (i.e., 9–10 TA cells plus one stem cell), along with the
stack of differentiated cells above them, are organized in a
spatially distinct proliferative compartment, called an ‘epidermal
proliferative unit’ (EPU). According to this model, if a basal stem
cell has undergone a mutation at the premature stop codon of the
stop-EGFP gene, only one EPU (occupying the area of a single
corneocyte on the skin surface) should become green fluorescent
(Fig 2D). However, Fig 2A shows that a cell lineage that
descended from a single epidermal stem cell can generate three
adjacent corneocytes (i.e., epidermal cells belonging to three
adjacent EPUs). The probability that the three corneocytes were
generated from more than one stem cell, each having undergone
independent mutation at the stop codon of the stop-EGFP gene, is
virtually zero because of the low frequency of mutation, ensuring
clonality. Thus, the finding suggests that a single stem cell is
capable of providing epidermal cells for at least three adjacent
EPUs by means of horizontal migration of either basal or
suprabasal cells (Fig 2E). Longitudinal optical sectioning of the
cell lineage (Fig 3) shows bright green fluorescent signals in the
basal layer beneath the hexagonal cells. To demonstrate that the
above finding is not restricted to young mice, mutations were also
induced in a 7-month-old stop-EGFP mouse by treatment with
ENU, and in vivo imaging of the dorsal skin was performed at 13
weeks post-ENU administration (i.e., after around 6.5 epidermal
turnovers). This imaging experiment also revealed an epidermal
stem-cell clonal lineage containing three neighbouring corneo-
cytes (Fig 2B) with green fluorescent signals in the basal layer (data
not shown). No green fluorescent epidermal cells were detected in
the dorsal skin of four untreated stop-EGFP mice, suggesting that
the green fluorescent cell lineages observed were generated in
adult mice exposed to ENU rather than arising because of the
spontaneous mutation.
Although the aforementioned EPU model is preferred for
describing the cellular proliferative structure in the mouse
epidermis, Potten (1981) considers the possibility of horizontal
migration of epidermal cells between EPUs. Supporting this idea,
Ghazizadeh & Taichman (2001) found that several adjacent
corneocytes were labelled when the epidermis was analysed at 37
weeks after infection of replication-deficient lacZ-carrying retro-
virus. Kameda et al (2003) also found expanded sizes of epidermal
cell lineages at 8–16 weeks after retrovirus infection encoding the
Fig 2 | Green fluorescent mutant colonies in the dorsal epidermis of ENU-treated stop-EGFP mice. (A) In vivo imaging of the dorsal epidermis of a
stop-EGFP mouse at 6 weeks post-ENU administration revealed an epidermal stem-cell clonal lineage containing three adjacent corneocytes. Bright
fluorescent signals within the hexagonal cells are from a deeper layer (see Fig 3). (B) Mutations were induced in a 7-month-old stop-EGFP mouse by
treatment with ENU and imaging of the dorsal skin was performed at 13 weeks post-ENU administration. The in vivo imaging experiment also
revealed an epidermal stem-cell clonal lineage containing three adjacent corneocytes. (C) In vivo imaging of the dorsal epidermis of another stop-EGFP
mouse at 18 days post-ENU administration revealed a green fluorescent mutant colony containing a single corneocyte on the skin surface. The cell
lineage was not detected when the same area of the dorsal epidermis was imaged again at 6 weeks post-ENU administration. (D) Schematic illustration
of epidermal proliferative units (EPUs). Adapted from Potten & Morris (1988). The arrow indicates vertical migration of epidermal cells for terminal
differentiation. According to the EPU model, a single stem cell having undergone a mutation at the premature stop codon of the stop-EGFP gene
should generate only one green fluorescent EPU (shown in green), which occupies the area of a single corneocyte on the skin surface. (E) Schematic
representation of an epidermal stem-cell clonal lineage containing three adjacent corneocytes detected in this study (shown in green), suggesting
migration of epidermal cells to adjacent EPUs. (A–C) Scale bars, 20 mm.
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lacZ gene. These data strongly suggest that a single stem cell can
contribute to multiple EPUs, although the possibility that those cell
lineages have originated from multiple stem cells in adjacent EPUs
cannot be completely ruled out because retrovirus can infect
multiple cells located nearby. That is, labelled multiple corneo-
cytes might be generated from each stem cell in their respective
EPUs, which is independently labelled by the retroviral infection.
Repeated imaging of the same area of the epidermis
At 18 days post-ENU administration, another stop-EGFP mouse
was anaesthetized and the dorsal skin was investigated. In contrast
to the epidermal cell lineage observed at 6 weeks post-ENU
administration (Fig 2A), the in vivo imaging experiment revealed
a green fluorescent mutant colony containing a single corneocyte
on the skin surface (Fig 2C). The same area of the epidermis was
imaged again at 6 weeks post-ENU administration, and the green
fluorescent cell lineage was not detected. Although we cannot
rule out the possibility that we accidentally missed the cell lineage
in the second imaging, we speculate that the cell lineage might
have originated from a TA cell, and thus had disappeared after
epidermal turnovers. Kameda et al (2003) also reported similar
observations. They found small epidermal cell lineages at 2–4
weeks after infection of lacZ-carrying retrovirus, but did not
observe this type of small cell lineage more than 10 weeks after
the retroviral infection. They suggested that these small cell
lineages had originated from TA cells and not from stem cells, and
thus had disappeared after tissue turnover (Kameda et al, 2003).
The epidermal cell lineage observed at 13 weeks post-ENU
administration (shown in Fig 2B) was detected again when the
same area of the skin was re-imaged at 16 weeks post-ENU
administration (data not shown), demonstrating that it is possible
to carry out repeated observations on stem-cell lineages over time
in a live mouse. The data from in vivo imaging of the epidermis of
ENU-treated stop-EGFP mice are summarized in supplementary
Table S1 online. In total, three epidermal cell lineages were
identified by in vivo imaging of five ENU-treated stop-EGFP mice.
Detection of green fluorescent mutants in other organs
To test the applicability of the stop-EGFP transgenic mouse
system to other organs, the kidney and liver were analysed at 5
months post-ENU administration. The organs were fixed in 4%
paraformaldehyde and sectioned into slices (200 mm in thickness)
using a vibratome (see supplementary information online). Each
slice was then analysed under a fluorescent microscope. In an
entire kidney from an ENU-treated stop-EGFP mouse, several
green fluorescent mutant cells were detected (Fig 4A,B). The
mutant cells contained what appeared to be brighter nuclei. The
bright spots were confirmed to be nuclei by 40,6-diamidino-2-
phenylindole (DAPI) staining (Fig 4A,B). In a scan of the entire
liver of an ENU-treated stop-EGFP mouse, a total of 26 mutations
were identified (Fig 4C,D). The number of mutations and
estimated total number of cells in each lobe are shown in
Table 1. Hepatocytes are normally proliferatively quiescent
without induced regeneration (Sell, 2001). In this study, a
mutant colony carrying more than two nuclei has not been
detected at 5 months post-ENU administration, and this may
reflect the slow rate of cell turnover in this tissue.
The stop-EGFP transgenic system can be applied to virtually
any tissue that undergoes constant renewal (e.g., epithelial tissues
of the gastrointestinal tract) or to tissues with episodic regenerative
capabilities. For example, if liver regeneration in an ENU-treated
stop-EGFP mouse is induced by partial hepatectomy or by
treatment with hepatoxic chemicals, clonal cell lineages could
be detected in the regenerated liver, which might provide insight
into the liver regeneration process. In our system, background
mutations were virtually undetectable because of an extremely
Fig 3 | Longitudinal optical sectioning of the epidermal cell lineage shown in Fig 2A. The reference depth, 0mm, was chosen arbitrarily as a depth
where a fairly bright signal was detected. The image was scanned at 4 mm intervals of depth, moving the focal plane vertically from the reference depth
to successively deeper layers. The brighter fluorescent signals seen in deeper optical sections are presumed to be basal cells or suprabasal cells. Each
image was taken using a  10 objective. Scale bars, 20 mm.
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low rate of spontaneous mutation (e.g., no mutations were
detected in the skin, kidney and liver of untreated stop-EGFP
mice); thus, cells can be labelled at a specific time point by
treatment with a pulse of mutagen. Therefore, imaging experi-
ments carried out after several tissue turnovers in a renewing tissue
of adult mice treated with a mutagen will allow one to specifically
trace cell lineages that descended from stem cells of the tissue.
The stop-EGFP system also has the potential to be applied to
tracing cell fates in developmental studies. For example, embryos
could be exposed to ENU in utero by exposing pregnant mice
to the mutagen (Winton et al, 1988). With the aim of allowing
a clonal cell lineage to be traced in developmental studies,
Bonnerot & Nicolas (1993) developed a transgenic mouse in
which infrequent (at the rate of 106 per cell generation)
Fig 4 | Green fluorescent mutant cells in the kidney and the liver. Panels A–D show merged images of EGFP signals and DAPI signals of mutant cells
detected in the kidney (A,B) and liver (C,D). The bright green fluorescent signals within these cells are colocalized with the DAPI-stained nuclei.
Scale bars, 10mm.
Table 1 | Observed distribution of stop-EGFP revertant mutations in four lobes of the liver
Lobe Mutation count Cell count Mutation frequency
Left caudal 12 (6.6172.32) 107 (1.8273.04) 107
Right anterior 6 (3.0670.84) 107 (1.9670.25) 107
Left anterior 1 (2.0470.32) 107 (0.4970.25) 107
Right caudal 7 (2.1870.43) 107 (3.2170.84) 107
All 26 (13.8971.99) 107 (1.8770.27) 107
The cell count is the estimated total number of cells in each lobe and the mutation frequency is the total number of mutations divided by the total number of cells. The total
number of cells in each lobe was estimated by multiplying the total cell number in a reference slice by the total number of slices of a similar size sectioned from the organ.
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spontaneous homologous recombination activates lacZ expres-
sion in tissues. The clonality of cell lineages generated during
development in this system is virtually certain owing to the low
frequency of spontaneous recombination events. The transgenic
mouse (referred to as the laacZ mouse) provided new insights into
the myotome formation and cerebellar development (Nicolas et al,
1996; Mathis & Nicolas, 2003). A problem with the laacZ mouse
system is that one cannot determine when during development
the recombination events occur, which leads to difficulties in
interpreting the data (Sanes, 1994). In the stop-EGFP system,
however, an extremely low rate of spontaneous mutation ensures
that cells are probably labelled at a specific time point during
development (by treatment with a pulse of mutagen), and this may
overcome this limitation of the laacZ system.
SPECULATION
Although we have only performed in vivo imaging of clonal
cell lineages in the epidermis in this study, a similar approach
could be applied to other organs such as the liver, muscle and
brain (Naumov et al, 1999; Chen et al, 2000; Feng et al,
2000). Repeated in vivo imaging of the same GFP-expressing
cells over time has recently been successfully performed in
these organs (Chen et al, 2000; Feng et al, 2000). If such
repeated in vivo imaging of the same tissue sites is performed
over time using our transgenic mouse system, one might be
able to investigate the dynamics of the clonal development of
a cell lineage in many different tissues (e.g., in the regenerat-
ing liver).
METHODS
Generation of the stop-EGFP and the wild-type EBFP genes. We
have obtained the plasmid pCX-EGFP, which was used to
generate a ‘green mouse’ (Okabe et al, 1997). The stop-EGFP
gene was generated from pCX-EGFP by PCR using the primers
STOPEGFP5 and 3EGFP (see supplementary information online
for primer sequences) and subsequently used to replace the
EGFP gene within pCX-EGFP. The new construct is referred to as
pCX-stop-EGFP. The wild-type EBFP gene was generated from
the wild-type EGFP gene using site-directed mutagenesis
(QuickChangeTM, Stratagene). The resulting construct is referred
to as pCX-EBFP.
Cell culture tests. To test the green fluorescence intensity of
protein expressed from each construct, a transfection experiment
was performed using the NIH3T3 mouse fibroblast cell line. The
procedures used followed the manufacturer’s guidelines (FuGENE
6 Transfection Reagent, Roche). At 36 h after transfection, the
transfected cells were imaged using an inverted fluorescent
microscope.
Animal experiments. All experiments using live mice were
performed in compliance with the recommendations of the
Canadian Council on Animal Care, and have been approved by
the Health Sciences Animal Policy and Welfare Committee of the
University of Alberta.
Generation of transgenic mice. The pCX-stop-EGFP and pCX-
EBFP constructs were digested with SalI and BamHI, and a DNA
fragment of 3.2 kb was purified. The 3.2 kb fragment from pCX-
stop-EGFP was mixed with that from pCX-EBFP, and then micro-
injected into fertilized oocytes using standard techniques. Geno-
types of mice were determined by genomic PCR using primers,
EGFPMIDDLE5 and 3EGFP (see supplementary information online
for primer sequences).
ENU administration. The procedures followed standard operating
protocols developed by the Office of Environmental Health &
Safety at the University of Alberta. Briefly, about 1 g of ENU
(ISOPAC, Sigma) was dissolved in 10 ml of 95% ethanol and then
90 ml of phosphate-citrate buffer (pH 5.0) was added to the ENU
solution. ENU at 150 mg/kg (single dose) was administered
intraperitoneally to each mouse.
In vivo detection of epidermal cell lineages. At one week before
the in vivo imaging experiment, the dorsal hair in telogen was
depilated (about 2.5 cm 2.5 cm area) using a depilatory agent
(Nair, Carter-Wallace Inc.). On the day of the imaging experiment,
the mouse was anaesthetized and placed with its dorsal skin on a
microscope coverslip on the microscope stage. The depilated area
of the epidermis was illuminated by a 50 W mercury lamp and
scanned using an inverted laser scanning confocal fluorescent
microscope (Zeiss LSM 510) with a  10 objective and an LP 520
emission filter (Zeiss). Green fluorescent mutant epidermal cells
were imaged using the microscope with an Argon laser (488 nm)
and a  10 objective.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
ACKNOWLEDGEMENTS
We thank P. Dickie, X. Sun and G. Hipperson for the technical
assistance. This research was supported by the 2002 CIHR Peter
Lougheed Scholar Award to B.R. from the Canadian Institutes of Health
Research and the Peter Lougheed Foundation.
REFERENCES
Allen TD, Potten CS (1974) Fine-structural identification and organization of
the epidermal proliferative unit. J Cell Sci 15: 291–319
Bonnerot C, Nicolas JF (1993) Clonal analysis in the intact mouse embryo by
intragenic homologous recombination. C R Acad Sci III 316: 1207–1217
Brazelton TR, Rossi FM, Keshet GI, Blau HM (2000) From marrow to brain:
expression of neuronal phenotypes in adult mice. Science 290:
1775–1779
Chen BE, Lendvai B, Nimchinsky EA, Burbach B, Fox K, Svoboda K (2000)
Imaging high-resolution structure of GFP-expressing neurons in
neocortex in vivo. Learn Mem 7: 433–441
Clarke JD, Tickle C (1999) Fate maps old and new. Nat Cell Biol 1:
E103–E109
Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M,
Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in
transgenic mice expressing multiple spectral variants of GFP. Neuron 28:
41–51
Flake AW (2001) Fate mapping of stem cells. In Stem Cell Biology,
Marshark DR, Gardner RL, Gottlieb D (eds) pp 375–397. Cold Spring
Harbor, NY: Cold Spring Harbor Laboratory Press
Ghazizadeh S, Taichman LB (2001) Multiple classes of stem cells in
cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J 15:
1215–1222
Heim R, Prasher DC, Tsien RY (1994) Wavelength mutations and
posttranslational autoxidation of green fluorescent protein. Proc Natl
Acad Sci USA 91: 12501–12504
Kameda T, Nakata A, Mizutani T, Terada K, Iba H, Sugiyama T (2003)
Analysis of the cellular heterogeneity in the basal layer of mouse ear
epidermis: an approach from partial decomposition in vitro and retroviral
cell marking in vivo. Exp Cell Res 283: 167–183
Mathis L, Nicolas JF (2003) Progressive restriction of cell fates in relation to
neuroepithelial cell mingling in the mouse cerebellum. Dev Biol 258:
20–31
Naumov GN, Wilson SM, MacDonald IC, Schmidt EE, Morris VL, Groom AC,
Hoffman RM, Chambers AF (1999) Cellular expression of green
fluorescent protein, coupled with high-resolution in vivo
Transgenic mouse in clonal cell lineage detection
S. Ro & B. Rannala
&2004 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 5 | NO 9 | 2004
scientificreport
919
videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 112:
1835–1842
Nicolas JF, Mathis L, Bonnerot C, Saurin W (1996) Evidence in the mouse for
self-renewing stem cells in the formation of a segmented longitudinal
structure, the myotome. Development 122: 2933–2946
Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y (1997) ‘Green
mice’ as a source of ubiquitous green cells. FEBS Lett 407: 313–319
Potten CS (1975) Epidermal transit times. Br J Dermatol 93: 649–658
Potten CS (1981) Cell replacement in epidermis (keratopoiesis) via discrete
units of proliferation. Int Rev Cytol 69: 271–318
Potten CS, Morris RJ (1988) Epithelial stem cells in vivo. J Cell Sci 10(Suppl):
45–62
Ro S, Rannala B (2001) Methylation patterns and mathematical models reveal
dynamics of stem cell turnover in the human colon. Proc Natl Acad Sci
USA 98: 10519–10521
Sanes JR (1994) Lineage tracing. The latest in lineage. Curr Biol 4: 1162–1164
Schneider TE, Barland C, Alex AM, Mancianti ML, Lu Y, Cleaver JE, Lawrence
HJ, Ghadially R (2003) Measuring stem cell frequency in epidermis: a
quantitative in vivo functional assay for long-term repopulating cells.
Proc Natl Acad Sci USA 100: 11412–11417
Sell S (2001) Heterogeneity and plasticity of hepatocyte lineage cells.
Hepatology 33: 738–750
Stern CD, Fraser SE (2001) Tracing the lineage of tracing cell lineages.
Nat Cell Biol 3: E216–E218
Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A,
Kaplan DR, Miller FD (2001) Isolation of multipotent adult stem cells
from the dermis of mammalian skin. Nat Cell Biol 3: 778–784
Van der Kooy D, Weiss S (2000) Why stem cells? Science 287: 1439–1441
Winton DJ, Blount MA, Ponder BA (1988) A clonal marker induced by
mutation in mouse intestinal epithelium. Nature 333: 463–466
Transgenic mouse in clonal cell lineage detection
S. Ro & B. Rannala
EMBO reports VOL 5 | NO 9 | 2004 &2004 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
scientificreport
920
